Among the soluble molecules analyzed, sPD1 was the only parameter that displayed a modulation after ICIs, showing an increase in the overall NSCLC population and the responding patients, even if the increase in this latter group was not statistically significant (p=0.06). This evidence concerns the gene HOXD13 and non-small cell lung carcinoma.